contract pharma | new approaches in bispecific antibody development
Published 1 year ago • 1.9K plays • Length 22:11Download video MP4
Download video MP3
Similar videos
-
30:15
manufacturing concepts for antibody-drug conjugates | webinar
-
12:27
what to consider in selecting the best cell line to accelerate the timeline to ind | bpi west
-
9:03
samsung biologics cdo capabilities
-
43:38
webinar - bispecific antibodies: the next generation of antibody therapeutics
-
27:16
on-demand webinar | enhancing quality by employing cell line replacement and process optimization
-
28:43
pharmtech | key considerations when selecting a mrna cdmo partner
-
44:50
the evolving role of the outsourcing manufacturer: why cdmo is the new normal
-
2:30
counting medicines’ carbon emissions
-
1:15
samsung biologics | drug product manufacturing
-
4:45
optimizing n-glycan profiles and their effector functions using a design of experiments approach
-
1:02:58
cdmo selection for bispecific antibody development
-
3:32
introducing next-generation antibodies
-
1:10
how does it work? | bispecific antibodies
-
15:33
engineering bispecific antibody targets for novel arsenal in immune therapy - sabpa 2022
-
1:04
samsung bioepis seeks new drug approval
-
46:47
bispecific antibody overview & production with crossmab technology
-
36:33
pharmapack 2020 - conference - understanding the complexities of delivering a biologic drug
-
21:58
business review | partnering with cdmos for a sustainable future
-
3:32
introducing next-generation antibodies